University of Chicago Section of Hematology/Oncology — Chicago, Illinois

University of Chicago Section of Hematology/Oncology is a clinical research site located in Chicago, Illinois, United States.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Chicago Section of Hematology/Oncology has participated in 3 clinical trials.

Therapeutic areas: Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Myelogenous Leukemia, Chronic.

Sponsors: Astellas Pharma Inc, Novartis Pharmaceuticals, OSI Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

• The University of Chicago Medicine Duchossois Center for Advanced Medicine
• Jeffrey Kramer, MDSC at Mercy Hospital
• University Consultants in Allergry and Immunology
• Rush University Med Ctr
• University of Illinois Medical Center in Chicago
• University of Chicago Medical Center (UCMC) Center for Advanced Medicine (CAM)
• Rush University Medical Center-Orthopedic Spine
• Northestern University
• University of Chicao
• Rush University Medical Center - Department Of Cardiology
• Northwestern University Diagnostic Testing Center
• University of Illinois Chicago

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Section of Hematology/Oncology?

University of Chicago Section of Hematology/Oncology has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Section of Hematology/Oncology conducted?

University of Chicago Section of Hematology/Oncology has 3 clinical trials on record. Their work covers Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Myelogenous Leukemia, Chronic.

Is University of Chicago Section of Hematology/Oncology accredited by Crixeo Clinical Trials?

University of Chicago Section of Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago Section of Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.